← Leaderboards
Ajay Goel
Baylor Research Institute
$17,151,605
Attributed
$23,239,067
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,239,067 · 9
By mechanism
R01$11,863,106 · 6
U01$11,375,961 · 3
Top collaborators
- Daniel D Von Hoff10 shared
- Dominik F Wodarz6 shared
- Clement Richard Boland4 shared
Most similar at Baylor Research Institute
Same institution · by research overlap
- Damien Chaussabel$8,586,543
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCohortDiagnosticBiological MarkersMessenger RnaPrognosticCessation Of LifeBioinformaticsPlasmaEarly DiagnosisCancer EtiologyColorectal CancerBiomarker DiscoveryTissuesBloodMicrornasGenome-WideMicrorna BiomarkersEvaluationPerformanceBaseBiomarker PanelValidationCells
Grant awards (46)
Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer$861,010
U01 · FY2025 · CA · contact PI
Exosomal biomarkers for the early detection of hepatocellular carcinoma$727,919
R01 · FY2025 · CA · contact PI
5mC and 5hmC DNA alterations as sensitive and specific biomarkers for the non-invasive early detection of pancreatic ductal adenocarcinoma$690,637
U01 · FY2025 · CA · contact PI
Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer$13,525
U01 · FY2025 · CA · contact PI
Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer$13,525
U01 · FY2025 · CA · contact PI
Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer$815,080
U01 · FY2024 · CA · contact PI
Exosomal biomarkers for the early detection of hepatocellular carcinoma$693,134
R01 · FY2024 · CA · contact PI
Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer$923,881
U01 · FY2023 · CA · contact PI
Exosomal biomarkers for the early detection of hepatocellular carcinoma$745,286
R01 · FY2023 · CA · contact PI
Exosomal Biomarkers for the Noninvasive Detection of Colorectal Cancer$487,903
R01 · FY2023 · CA · contact PI
Exosomal Biomarkers for the Noninvasive Detection of Colorectal Cancer$508,313
R01 · FY2022 · CA · contact PI
Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer$1,445,861
U01 · FY2021 · CA · contact PI
Exosomal Biomarkers for the Noninvasive Detection of Colorectal Cancer$514,464
R01 · FY2021 · CA · contact PI
Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer$718,747
U01 · FY2020 · CA · contact PI
Exosomal Biomarkers for the Noninvasive Detection of Colorectal Cancer$507,906
R01 · FY2020 · CA · contact PI
MicroRNA Biomarkers for Determining Treatment Response in Colorectal Cancer$405,048
R01 · FY2020 · CA · contact PI
Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer$1,099,737
U01 · FY2019 · CA · contact PI
Exosomal Biomarkers for the Noninvasive Detection of Colorectal Cancer$501,433
R01 · FY2019 · CA · contact PI
Familial and Early Onset Colorectal Cancer$405,460
R01 · FY2019 · CA · contact PI
MicroRNA Biomarkers for Determining Treatment Response in Colorectal Cancer$393,203
R01 · FY2019 · CA · contact PI
Development of microRNA Biomarkers For Noninvasive Detection of Colorectal Cancer$392,396
R01 · FY2019 · CA · contact PI
Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer$1,020,224
U01 · FY2018 · CA · contact PI
Familial and Early Onset Colorectal Cancer$372,400
R01 · FY2018 · CA · contact PI
Aspirin and Cancer Prevention in Lynch Syndrome: From Cell to Population Data$353,409
U01 · FY2018 · CA · contact PI
MicroRNA Biomarkers for Determining Treatment Response in Colorectal Cancer$349,694
R01 · FY2018 · CA · contact PI
Development of microRNA Biomarkers For Noninvasive Detection of Colorectal Cancer$347,517
R01 · FY2018 · CA · contact PI
METHYLATION BIOMARKER DEVELOPMENT FOR NONINVASIVE DETECTION OF COLORECTAL CANCER$222,518
R01 · FY2018 · CA · contact PI
Aspirin and Cancer Prevention in Lynch Syndrome: From Cell to Population Data$125,845
U01 · FY2018 · CA · contact PI
Methylation Biomarker Development for Noninvasive Detection of Colorectal Cancer$107,883
R01 · FY2018 · CA · contact PI
Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer$1,075,356
U01 · FY2017 · CA · contact PI
Aspirin and Cancer Prevention in Lynch Syndrome: From Cell to Population Data$496,015
U01 · FY2017 · CA · contact PI
Familial and Early Onset Colorectal Cancer$372,400
R01 · FY2017 · CA · contact PI
MicroRNA Biomarkers for Determining Treatment Response in Colorectal Cancer$352,363
R01 · FY2017 · CA · contact PI
Development of microRNA Biomarkers For Noninvasive Detection of Colorectal Cancer$349,917
R01 · FY2017 · CA · contact PI
METHYLATION BIOMARKER DEVELOPMENT FOR NONINVASIVE DETECTION OF COLORECTAL CANCER$315,983
R01 · FY2017 · CA · contact PI
Aspirin and Cancer Prevention in Lynch Syndrome: From Cell to Population Data$555,997
U01 · FY2016 · CA · contact PI
Familial and Early Onset Colorectal Cancer$372,400
R01 · FY2016 · CA · contact PI
MicroRNA Biomarkers for Determining Treatment Response in Colorectal Cancer$360,913
R01 · FY2016 · CA · contact PI
Development of microRNA Biomarkers For Noninvasive Detection of Colorectal Cancer$359,828
R01 · FY2016 · CA · contact PI
METHYLATION BIOMARKER DEVELOPMENT FOR NONINVASIVE DETECTION OF COLORECTAL CANCER$315,983
R01 · FY2016 · CA · contact PI
Aspirin and Cancer Prevention in Lynch Syndrome: From Cell to Population Data$571,122
U01 · FY2015 · CA · contact PI
Familial and Early Onset Colorectal Cancer$372,400
R01 · FY2015 · CA · contact PI
Development of microRNA Biomarkers For Noninvasive Detection of Colorectal Cancer$360,402
R01 · FY2015 · CA · contact PI
METHYLATION BIOMARKER DEVELOPMENT FOR NONINVASIVE DETECTION OF COLORECTAL CANCER$320,751
R01 · FY2015 · CA · contact PI
Aspirin and Cancer Prevention in Lynch Syndrome: From Cell to Population Data$595,990
U01 · FY2014 · CA · contact PI
METHYLATION BIOMARKER DEVELOPMENT FOR NONINVASIVE DETECTION OF COLORECTAL CANCER$327,289
R01 · FY2014 · CA · contact PI